Publications

Publications keep interested parties informed about the latest scientific, clinical, trial-based, and peer-reviewed documentation about our products and pipeline. Find the latest below:

Publications
Sort by :
2026 cardiometabolic

Expanding Patient Choice in Diabetes Care: Reducing Access Barriers to Inhaled Insulin

Diabetes Technology & Therapeutics
Published Online: October 19, 2026
2026 cardiometabolic

Experiences With Inhaled Insulin in a Real-World Sample of Adults With Type 1 Diabetes in the T1D Exchange Registry

The Science of Diabetes Self-Management and Care
September 7, 2026, Volume 52, Issue 5, Pages 393-405
2026 cardiometabolic

Inhaled Insulin Dosing in a Randomized Trial in Adults With Type 1 Diabetes

AACE Endocrinology and Diabetes
May-June 2026, Volume 13 Issue 3, Pages 428-435
2026 cardiometabolic

Inhaled Technosphere Insulin Reduces Postmeal Glucose Excursion in Youth Living with Type 1 Diabetes

Diabetes Technology & Therapeutics
Published Online: March 14, 2026
2026 cardiometabolic

Inhaled Technosphere Insulin in Children with Diabetes: The INHALE-1 Extension Study

Diabetes Technology & Therapeutics
Published Online: February 4, 2026
2026 cardiometabolic

Role of Ultra-Rapid Acting Insulin in Managing Diabetes

Diabetes Technology & Therapeutics
February 1, 2026, Volume 28 Issue 1 Pages 1S – 5S
2026 cardiometabolic

30 Years of Developing Inhaled Insulin

Diabetes Technology & Therapeutics
February 1, 2026, Volume 28 Issue 1 Pages 6S – 7S
2026 cardiometabolic

Dosing Afrezza: It's Not that Complicated

Diabetes Technology & Therapeutics
February 1, 2026, Volume 28 Issue 1 Pages 8S – 13S
2026 cardiometabolic

Unmet Needs in Insulin-Treated Diabetes Management

Diabetes Technology & Therapeutics
February 1, 2026, Volume 28 Issue 1 Pages 14S – 18S
2026 cardiometabolic

Pulmonary Safety and Clinical Considerations for Inhaled Insulin: A Comprehensive Review

Diabetes Technology & Therapeutics
February 1, 2026, Volume 28 Issue 1 Pages 19S – 25S
2026 cardiometabolic

Impact of Inhaled Insulin Therapy on Hypoglycemia

Diabetes Technology & Therapeutics
February 1, 2026, Volume 28 Issue 1 Pages 26S – 30S
2026 cardiometabolic

Potential Applications of Inhaled Insulin in Diabetic Ketoacidosis Prevention and During Exercise: Two Case Presentations

Diabetes Technology & Therapeutics
February 1, 2026, Volume 28 Issue 1 Pages 31S – 37S
Sort by :
2019 cardiometabolic

A Pragmatic Clinical Trial to Compare the Real-World Effectiveness of V-Go versus Standard Delivery of Insulin in Patients with Advanced Type 2 Diabetes

J Health Econ Outcomes Res.
2019; 6(2): 70-83
2019 cardiometabolic

Effect of V-Go Versus Multiple Daily Injections on Glycemic Control, Insulin Use, and Diabetes Medication Costs Among Individuals with Type 2 Diabetes Mellitus

J Manag Care Spec Pharm.
2019; 25(10): 1111-23
2019 cardiometabolic

Clinical and economic considerations based on persistency with a novel insulin delivery device versus conventional insulin delivery in patients with type 2 diabetes: A retrospective analysis

Res Social Adm Pharm.
2019; 15(9): 1126-32
2018 cardiometabolic

Clinical Benefits Over Time Associated with Use of V-Go Wearable Insulin Delivery Device in Adult Patients with Diabetes: A Retrospective Analysis

Adv Ther.
2018; 35: 631-43
2018 cardiometabolic

Subcutaneous furosemide in heart failure: pharmacokinetic characteristics of a newly buffered solution.

JACC BASIC TRANSLATIONAL SCIENCE
2018; 3(1): 25-34.
2018 cardiometabolic

Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study.

Diabetes Technol
2018; 20(10): 639-647
2017 cardiometabolic

Efficacy of Intravenous Furosemide Versus a Novel, pH-Neutral Furosemide Formulation Administered Subcutaneously in Outpatients With Worsening Heart Failure

JACC Heart Failure
December 6, 2017, Volume 6 Number 1, Pages 65-70
2017 cardiometabolic

A Population Dose-Response Model for Inhaled Technosphere Insulin Administered to Healthy Subjects.

CPT Pharmacometrics Syst. Pharmacol
2017; 6: 365-72
2017 cardiometabolic

The Need for Faster Insulin: Problem Solved?

J. Diabetes Sci. Technol.
2017; 11(1): 157–159
2017 cardiometabolic

Pharmacokinetic and Pharmacodynamic Properties of a Novel Inhaled Insulin.

J. Diabetes Sci. Technol
2017; 11(1): 148–156
2016 cardiometabolic

Impact of symptomatic upper respiratory tract infections on insulin absorption and action of Technosphere inhaled Insulin

BMJ Open Diabetes Res. Care
2016; 4: e000228
2016 cardiometabolic

The Clinical and Economic Impact of the V-Go® Disposable Insulin Delivery Device for Insulin Delivery in Patients with Poorly Controlled Diabetes at High Risk

Drugs Real World Outcomes
2016; 3: 191-99